Brachiobasilic Fistula Formation – Single versus Two Stage Procedure  by Robertson, B.F. et al.
Brachiobasilic Fistula Formation e Single versus Two Stage Procedure
B.F. Robertson, G.A. Robertson, L. Khan, Z. Raza *
Royal Inﬁrmary, Edinburgh, United Kingdom* Co
burgh,
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
This is an original article comparing one and two stage methods of brachiobasilic ﬁstula formation.We identiﬁed
no difference between the two methods in terms of patency. Fistulae created prior to starting dialysis had
a signiﬁcantly longer survival compared to those created in patients who were already undergoing dialysis
treatment at the time of creation.Background: Brachial Basilic (BB) ﬁstulae are a form of vascular access for patients requiring dialysis. They are
indicated when the cephalic vein is unsuitable for use. This ﬁstula can be created with either a single stage or
a two stage procedure. We aimed to compare the two techniques.
Methods: 73 BB ﬁstulae (29 single and 44 two-stage) were created over a 5-year period (2003e2008). Data
including sex, age, dialysis and diabetic status was collected from the case notes. Patency and time to maturity
data was collected prospectively on an electronic database within the dialysis unit.
Results: There was no signiﬁcant difference in functional patency rates between the two methods. A signiﬁcant
difference was identiﬁed between patients who had their ﬁstula created prior to starting dialysis compared to
those who had their ﬁstula created after starting dialysis, in both initial patency rate (p ¼ 0.017) and long term
survival of the ﬁstulae (p ¼ 0.002).
Conclusion: We identiﬁed no signiﬁcant difference of patency between the two methods. This implies that
a single stage procedure has beneﬁts, by offering a quicker form of vascular access. Patients who had their
ﬁstulae created prior to dialysis had improved patency rates.
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Since the creation of the ﬁrst autologous Arteriovenous (AVF)
ﬁstula in 1966,1 vascular access provision has become an
increasingly common elective procedure. Previous papers
have emphasised the many beneﬁts; namely decreased
morbidity, mortality, and prolonged survival, for patients who
receive dialysis through an AVF.2,3 In 1979, a new form of
ﬁstulawas describede the brachial basilic (BB)ﬁstula.4 The BB
ﬁstula is considered as an optionwhen either previous ﬁstulae
have failed, or when the cephalic vein is unsuitable for use.5
BB AVFs can either be created by one of two methods e
a single stage or a two stage procedure. The single stage
procedure is carried out as an inpatient under general
anaesthetic or a brachial plexus block. The two stage
procedure involves two operations. Each method has
different beneﬁts and drawbacks. A single stage procedure
provides a quicker method of vascular access and a shorter
total stay in hospital. The two stage procedure subjects therresponding author. Z. Raza, Vascular Unit, Royal Inﬁrmary, Edin-
Little France, Edinburgh EH16 4SA, United Kingdom.
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//dx.doi.org/10.1016/j.ejvs.2013.03.003patient to two operations, more time in hospital and as it
involves two hospital visits is more costly. If after the ﬁrst
stage, the vein has not adequately matured, the patient
may be spared a bigger operation, or a revision of the ﬁstula
can be performed during the second stage of creation. One
stage formation potentially uses less resources and less
theatre time when compared to a two stage procedure.
There is evidence to suggest that BB ﬁstulae have a good
outcome6e10 and comparable patency rates to cephalic
ﬁstulae.5,10,11 However, there is currently no evidence that
exists stating whether a single stage method of creation is
superior or not to the two stage method. There are no
national guidelines on performing the procedure in a single
or two stages. We therefore performed a retrospective
observational study to evaluate whether creating a BB AVF
by a single or a two stage method provides a better outcome
in terms of patency and feasibility, and whether there are
any other associated factors that affect the patency.METHODS
All patients who had a BB ﬁstula created within the Royal
Inﬁrmary of Edinburgh were identiﬁed using the Fistula
Audit Database and PROTON (electronic database of
patients with all grades of renal dysfunction within South
Table 1. Clinical characteristics of patients.
1 Stage 2 Stage Signiﬁcance
No. of AVF 29 44
Age (range) 56.9 (20e82) 61.7 (18e81) p ¼ 0.160
Right:Left 12:17 10:34 p ¼ 0.119
Diabetic 6 18 p ¼ 0.081
M:F 16:13 22:22 p ¼ 0.811
Pre-HD:Post-HD 7:22 24:20 p ¼ 0.015
No. of AVF, number of AVF created; M:F, Male:Female; Pre-
HD:Post-HD, ﬁstula created before commencing
haemodialysis:fistula created after commencing dialysis; NS, not
signiﬁcant.
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The data collected included age at ﬁstula creation, sex,
single stage or two stage, diabetic status, dead or alive,
dialysis status and date commencing dialysis if on dialysis,
number of previous procedures and any revision procedures
post creation. The total number of patients identiﬁed were
73 (29 single stage; 44 two stage).
All patients who were referred for a BB AVF underwent
pre-assessment and underwent duplex scans to assess
suitability for the ﬁstula. A BB AVF was only considered if
the vein diameter was at least 2.5 mm. All BB AVFs were
created by two consultant vascular surgeons with
a specialist interest in AVF creation. The decision to perform
a single or two stage procedure was based on the patient
preference, operating time available and urgency of ﬁstula
required. The decision was not inﬂuenced by vein diameter,
nor was it randomised. Patients who were undergoing
dialysis treatment may have been more likely to have their
ﬁstula created by a one stage procedure, with the inten-
tions of offering a quicker form of vascular access.
In our unit, all single stage procedures were carried out
as an inpatient under general anaesthetic.12 The two stage
procedure13 involves the initial anastomosis of the brachial
artery and basilic vein as a day case, which was performed
under local anaesthetic. Approximately six weeks later, the
patients underwent a duplex scan to assess whether or not
the vein had adequately matured. If the vein had matured
the patient was then referred for the second stage. If the
vein had not matured it was allowed further time to
mature, with regular monitoring within the dialysis unit.
Once mature, the ﬁstula was elevated and transposed
laterally to a more superﬁcial location to allow easy can-
nulation.14 All second operations were carried out as an
inpatient procedure under general anaesthetic. Drains were
inserted into the arms, following all single stage procedures
and second operations of the two stage procedures. Drains
were removed at approximately twenty-four hours, with
a mean in patient stay of 1.5 days.
All ﬁstulae were scanned at 4e6 weeks post creation.
Maturation was determined and deﬁned by a minimum vein
diameter of 5 mm, a ﬂow rate of greater than 500ml/min and
assessment by the Vascular Access Nurse that the ﬁstula was
suitable for cannulation. This was documented prospectively
on an electronic database by staff within the dialysis unit
(PROTON).
All ﬁstulae that failed were subjected to a Doppler
ultrasound scan to identify the possible aetiology for failure.
Fistulae that had thrombosed were treated with interven-
tion and then reassessed at two weeks. Fistulae that had
failed to mature were monitored within the dialysis unit
until maturation. Patients who died with a patent ﬁstula
were considered lost to follow up. Patients who had a two
stage procedure were classed as not having started dialysis
if they were not being dialysed at the time of the ﬁrst
operation. Four patients commenced dialysis in between
the two stages of operation through a permcath until the
second stage of the procedure. They were considered to be
predialysis at the time of ﬁstula creation.Statistical analysis was carried out using Statistical
Package for the Social Sciences, (SPSS, Chicago) version 19.
Comparisons of clinical characteristics between the two
groups were calculated using the c2 and Fischer’s Exact test.
Analysis of variance was used to compare median values
between the two groups. The log-rank test was performed
in conjunction with the KaplaneMeier method for survival
analysis to compare AVF long term patency. A p value <0.05
was deemed to be statistically signiﬁcant.RESULTS
Seventy-three patients had a BB ﬁstula created over a six-
year period between November 2002 and November 2008
at the Royal Inﬁrmary of Edinburgh. The characteristics of
the two groups are summarised in Table 1. Of the 73
patients, 29 (39.7%) had their ﬁstula created as a single
stage and 44 (60.3%) had their AVF created as a two stage
procedure. Of the two stage patients, there was a median
3.6 months (range 1.5e9.3 months) delay between the two
operations. This delay reﬂected theatre availability, patient
co morbidity and time extension to allow the ﬁstula to
mature further. The second stage of all two stage patients,
excluding one, was completed. The BB ﬁstula was the ﬁrst
form of vascular access in 8 out of 29 single stage patients,
and this was statistically lower than 27 of the 44 two stage
patients (p ¼ 0.008).
There was a 76% functional patency rate at 6 weeks for all
the single stage ﬁstulae. This was comparable to 84% in the
two stage ﬁstulae (p ¼ 0.545). The seven single stage ﬁstulas
that were not patent at 6 weeks, three (10%) had failed to
mature and four (14%) had thrombosed. All ﬁstulae were
followed up for a median period of 15 months (range 1.5e
56 months). Life table analysis with the log rank test showed
no signiﬁcant difference (p ¼ 0.431) when comparing long
term patency between the two methods of creation (Fig. 1).
Six (21%) single stage patients underwent revisional
surgical or radiological procedures for failing ﬁstulae. One
patient (3%) had a revision of their anastomosis, two
patients (7%) underwent thromboembolectomy and three
patients (10%) had percutaneous angioplasty. Similarly
seven (16%) two stage patients had revision procedures
performed on their ﬁstulae and three (7%) underwent
thromboembolectomies, and a further three (7%) had
Figure 1. Primary patency rates comparing 1 stage vs 2 stage BB
ﬁstulae (p ¼ 0.431).
Figure 2. Primary patency rates comparing BB ﬁstulae created Pre-
HD (prior to commencing dialysis) vs Post-HD (in patient under-
going treatment by dialysis) (p ¼ 0.002).
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of a stenosis.
Secondary patency rates were similar between the two
groups with one stage 86.2% which was comparable to
90.6% of the two stage procedures. This difference was not
signiﬁcant (p ¼ 0.706).
Clinical characteristics were then examined to assess
whether they affected the outcome of the functional
patency of the ﬁstulas at six weeks (Table 2). Sex, diabetic
status and which arm the ﬁstula was situated were all non-
signiﬁcant factors. However when comparing those who
had their ﬁstula created before starting dialysis (Pre-HD)
with those who had their ﬁstula created whilst on dialysis
(Post-HD), there were signiﬁcant differences. Twenty-nine
(93.5%) out of 31 patients who had their ﬁstula created Pre-
HD had a patent ﬁstula at 6 weeks compared to 29 (70.7%)
out of 41 patients who had their ﬁstula created whilst on
dialysis had a patent AVF at 6 weeks. The difference was
statistically signiﬁcant (p ¼ 0.015). The two patients in the
Pre-HD group whose AVF was not working at 6 weeks,
commenced dialysis before undergoing the second stage of
a two stage procedure. Two other patients who were clas-
siﬁed in the Pre-HD group also commenced dialysis before
undergoing the second operation, however their AVFs were
mature and patent at 6 weeks. When assessing the differ-
ences in long term patency between the two groups (Fig. 2),
we found that ﬁstulae created in the Pre-HD patients hadTable 2. Functional patency rates at 6 weeks.
Functioning Not functioning Statistics
1 Stage 22 (75.9%) 7 (24.1%) p ¼ 0.545
2 Stage 36 (83.7%) 7 (16.3%)
Created Pre-HD 29 (93.5%) 2 (6.5%) p ¼ 0.017
Created Post-HD 29 (70.7%) 12 (29.3%)
Diabetic 17 (73.9%) 6 (26.1%) p ¼ 0.327
Non-diabetic 41 (85.4%) 7 (14.6%)
Diabetic Pre-HD 10 (90.9%) 1 (9.1%) p ¼ 0.155
Diabetic Post-HD 7 (58.3%) 5 (41.7%)
Non-diab Pre-HD 18 (94.7%) 1 (5.3%) p ¼ 0.219
Non-diab Post-HD 23 (79.3%) 6 (20.7%)
Pre-HD ¼ ﬁstula created before commencing dialysis.Post-
HD ¼ ﬁstula created after commencing dialysis.Non-diab ¼ non-
diabetic.statistically signiﬁcant improved long term patency rates
when compared to the Post-HD group (p ¼ 0.002) (Table 3).
DISCUSSION
Brachial-basilic AVFs are reliable forms of vascular access.5e
10 A recent similar study by Reynolds et al.,16 identiﬁed
differences in patency between the two methods of crea-
tion. They compared 60 one stage with 30 two stage ﬁstulae
created at two different sites by an unspeciﬁed number of
surgeons. They found signiﬁcant differences in primary
patency at one (61% vs 88%: p ¼ 0.047) and two years (34%
vs 88%: p ¼ 0.047) in favour of the two stage method. They
also found signiﬁcant differences in secondary patency at
two years (41% vs 94%: p ¼ 0.015) again in favour of the
two stage method. Although they identiﬁed signiﬁcant
differences the causes of these differences remain unclear
and the numbers are relatively small.
Although we did not observe any signiﬁcant difference
between methods, when comparing patency, it was clear
that AVFs created in patients who had not commenced
dialysis treatment fared much better compared with those
created in patients who had already started treatment on
dialysis. This may be related to several factors including,
general health of the patients, uraemia and central line
induced arterial stenosis. This may also be partially due to
the fact that these AVFs in use are repeatedly cannulatedTable 3. Functional patency rates at six months.
Functioning Not functioning Statistics
1 Stage 25 (86.2%) 4 (13.8%) p ¼ 0.706
2 Stage 39 (90.6%) 4 (9.4%)
Created Pre-HD 31 (100%) 0 (0%) p ¼ 0.009
Created Post-HD 33 (80.5%) 8 (19.5%)
Diabetic 19 (82.6%) 4 (17.4%) p ¼ 0.203
Non-diabetic 45 (91.8%) 4 (8.2%)
Diabetic Pre-HD 11 (100%) 0 (0%) p ¼ 0.135
Diabetic Post-HD 8 (66.7%) 4 (33.3%)
Non-diab Pre-HD 20 (100%) 0 (0%) p ¼ 0.142
Non-diab Post-HD 25 (86.2%) 4 (13.8%)
Pre-HD ¼ ﬁstula created before commencing dialysis.Post-
HD ¼ ﬁstula created after commencing dialysis.Non-diab ¼ non-
diabetic.
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acknowledge that these factors are unproven and feel that
further research on a larger scale study is needed to look
into possible causes for this. However this data encourages
the early and timely creation of vascular access in patients
who will require dialysis.
One beneﬁt that the single stage method has when
compared with the two stage, is the avoidance of damage
to the medial anti-brachial cutaneous nerve and the medial
cutaneous nerve of the forearm. These nerves supply
sensation to regions in the arm and sit lateral and super-
ﬁcial to the basilic vein and encircle it. In a single stage, as
the vein is disconnected and dissected free, there is no
need to signiﬁcantly disturb local anatomy. However during
the transposition stage of a two stage procedure, these
nerves often lock down the vein and oppose the trans-
position. As such they are sacriﬁced, and as a result,
patients often can experience numbness and pain in the
relevant distribution within the arm. This data and any
complications arising from this, were not accurately recor-
ded in the notes and was therefore unable to be assessed.
Some surgeons advocate performing a second anastomosis
at the second operation which potentially avoid such
problems.15 In our unit we did not want to disturb
a working anastomosis and cause further scarring and
therefore did not disconnect and reconnect the ﬁstula.
We accept that our study may have some limitations, as
the decision for the method of creation for a single or a two
stage procedure was not randomised and it would be
difﬁcult to eliminate bias given the retrospective nature of
this study. In our study there was a signiﬁcantly higher
percentage of one stage patients undergoing dialysis at the
time of ﬁstula creation compared to two stage patients.
However in this clinical situation justifying randomisation
could be difﬁcult, especially when patients who have star-
ted dialysis require vascular access as soon as possible, thus
directing the surgeon towards a single stage procedure.
Despite this, our ﬁndings do shed some insight into patient
outcome who are exposed to a single or a two stage BB
ﬁstula creation.
In summary, this study has been unable to show any
signiﬁcant difference in outcome between the two methods
of creation. This is in contrast to the study by Reynolds
et al.,16 where they found better long term patency results
with the two staged method. Fistulae created in patients
who have not started dialysis have a much improved
patency rate when compared to those currently on dialysis
at the time of ﬁstula creation. All ﬁstulae created by the ﬁrst
part of a two stage procedure matured adequately to allow
the second stage to be performed. Creating a BB ﬁstula
using a single stage technique provides a quicker method for
patients needing to undertake subsequent dialysis. We feel
this method should therefore be the technique of choice in
most patients, when considering a BB ﬁstula creation.
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